Vendor, Louisville, CO
Sachi Bioworks, Inc.
UEI NTKPGKZLXPC1, CAGE 8L8S8
3 awards and $7,059,767 obligated between March 18, 2024 and August 20, 2026, 100% under full and open competition, against 500.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $7,059,767 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 3 |
| Small Business Set Aside - Total | 3 |
| Definitive Contract | 3 |
Hear when Sachi Bioworks, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of Sachi Bioworks, Inc.'s contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to National Aeronautics and Space Administration, by dollars.
| Lockheed Martin Corp.Littleton, CO | $8,278,547,865 |
| California Institute of TechnologyPasadena, CA | $6,231,150,177 |
| Amentum Technology, Inc.Tullahoma, TN | $2,723,293,029 |
| KBR Wyle Services, LLCLanham, MD | $2,535,718,957 |
| Blue Origin Washington, LLCKent, WA | $1,846,560,872 |
| Amentum Technology, Inc.Tullahoma, TN | $1,545,362,258 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 80NSSC23CA171Definitive Contract, July 30, 2024, Full and Open Competition After Exclusion of Sources, 500 offers | NASA Shared Services CenterNational Aeronautics and Space Administration | SBIR Phase III Rapid, LOW-COST Nanoligomertm Based Drug-Discovery in SpaceNAICS 541715, PSC AJ14 | $4,450,000 |
| 80NSSC24CA006Definitive Contract, March 18, 2024, Full and Open Competition After Exclusion of Sources, 500 offers | NASA Shared Services CenterNational Aeronautics and Space Administration | SBIR Phase III - Reversing Immune Dysregulation During Spaceflight MissionsNAICS 541715, PSC AJ14 | $2,234,767 |
| 80NSSC22CA116Definitive Contract, March 26, 2024, Full and Open Competition After Exclusion of Sources, 500 offers | NASA Shared Services CenterNational Aeronautics and Space Administration | E014042 SBIR Phase II Reversing Immune Dysregulation During Spaceflight MissionsNAICS 541715, PSC AJ14 | $375,000 |
- Places of performance
- Colorado
- Product and service codes
- AJ14 General Science And Technology R&D Services; General Science And Technology; R&D Administrative Expenses
- Transactions
- 19 across 3 awards